This is CNBC’s live blog covering all the latest news on the coronavirus outbreak. This blog will be updated throughout the day as the news breaks.
The United States has fully vaccinated about 13.5% of its adult population as of Friday, according to data from the Centers for Disease Control and Prevention. The CDC said at least 107 million Covid-19 vaccine doses have been administered in the U.S., a milestone that includes 16.5 million vaccines administered under the Trump administration. Yet, White House Chief Medical Advisor Dr. Anthony Fauci on Sunday warned Americans to continue with public health measures, like wearing masks, to avoid new infection spikes such as those being experienced in Europe.
The U.S. is recording at least 53,670 new Covid-19 cases and at least 1,354 virus-related deaths each day, based on a seven-day average calculated by CNBC using Johns Hopkins University data.
The following data was compiled by Johns Hopkins University:
- Global cases: More than 119.94 million
- Global deaths: At least 2.65 million
- U.S. cases: More than 29.43 million
- U.S. deaths: At least 534,889
Ireland, Netherlands join growing list of countries to suspend use of AstraZeneca vaccine
Ireland and the Netherlands have become the latest countries to suspend the use of the coronavirus vaccine developed by AstraZeneca and the University of Oxford over safety concerns.
Several European countries, including Denmark, Norway, Iceland and Bulgaria, have already paused the use of the Oxford-AstraZeneca vaccine following reports of blood clots in some vaccinated people. Thailand became the first Asian country to halt the use of the jab last week.
The Dutch government has said the Oxford-AstraZeneca vaccine would not be used nationwide until at least March 29, while Ireland said earlier in the day that it had temporarily suspended the shot as a precautionary step.
The World Health Organization has sought to downplay ongoing safety concerns, saying last week that there is no link between the shot and an increased risk of developing blood clots.
JetBlue says bookings are picking up as industry turns a corner
“Although booking trends remain choppy, in recent weeks JetBlue has experienced an improvement in bookings by leisure and visiting friends and relatives…” JetBlue says in a filing.
New York-based JetBlue says it expects its EBITDA to be a negative $490 million and $540 million, down from a previous estimate of losses of $525 million to as much as $625 million. First-quarter revenue will still be down 61% to 64% from 2019 in the first quarter of the year, it estimated, after previously forecasting a decline of as much as 70%.
JetBlue shares are up 4.7% in premarket trading.